MedPath

Allertein Therapeutics, LLC

Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

Peanut Allergy Vaccine Study in Healthy and Peanut-allergic Adults

Phase 1
Completed
Conditions
Food Hypersensitivity
Hypersensitivity
Immediate Hypersensitivity
Peanut Hypersensitivity
First Posted Date
2009-02-25
Last Posted Date
2013-05-27
Lead Sponsor
Allertein Therapeutics, LLC
Target Recruit Count
15
Registration Number
NCT00850668
Locations
🇺🇸

Johns Hopkins University, Baltimore, Maryland, United States

🇺🇸

Mount Sinai Medical Center, New York, New York, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.